NSWIn ForceAct
Drug Misuse and Trafficking Act 1985
Schedule 1
Start here
Get a plain-English read of Schedule 1
Turn the raw legal text into a practical explanation grounded in Drug Misuse and Trafficking Act 1985.
# Schedule 1
Schedule 1
(Sections 3 (1), 33 (4), 44)
| Prohibited plant or prohibited drug | Column 1 | Column 2 | Column 3 | Column 4 | Column 5 | Column 6 |
| Traffickable quantity | Small quantity | Indictable quantity | Commercial quantity | Large commercial quantity | Discrete dosage unit (DDU) |
| Acetorphine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Acetyl-alpha-methylfentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| N-acetylamphetamine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| Acetyldihydrocodeine | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Acetylmethadol | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| N-acetylmethylamphetamine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| N-(1-adamantyl)-1-pentyl-indazole-3-carboxamide (APINACA or AKB48) | 30g | 10g | 50g | 1kg | 4kg | — |
| Alfentanil | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Allylprodine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Alpha-acetylmethadol | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Alphameprodine | 0.3g | 0.1g | 0.5g | 0.05kg | 0.2kg | — |
| Alphamethylfentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Alpha-methylthiofentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Alphaprodine | 37.5g | 12.5g | 62.5g | 6.25kg | 25.0kg | — |
| Alpha-pyrrolidinovalerophenone (alpha-PVP) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| Alprazolam | 15g | 5g | 25g | 1.25kg | 5kg | — |
| N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) | 30g | 10g | 50g | 1kg | 4kg | — |
| N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) | 30g | 10g | 50g | 1kg | 4kg | — |
| N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) | 30g | 10g | 50g | 1kg | 4kg | — |
| 2-aminoindane | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 6-(2-aminopropyl)benzofuran (6-APB) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 5-(2-aminopropyl)indan | 3g | 1g | 5g | 0.25kg | 1kg | — |
| Amphetamine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| Amylobarbitone | 30.g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| Anabolic and androgenic steroidal agents | 500g | 50g | 750g | 5kg | — | — |
| Anileridine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Atamestane | 500g | 50g | 750g | 5kg | — | — |
| Benzethidine | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Benzylmorphine (3-benzylmorphine) | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| 1-Benzylpiperazine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Beta-hydroxyfentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Beta-hydroxy-3-methylfentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Betameprodine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Betaprodine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Bezitramide | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Bolandiol | 500g | 50g | 750g | 5kg | — | — |
| Bolasterone | 500g | 50g | 750g | 5kg | — | — |
| Bolazine | 500g | 50g | 750g | 5kg | — | — |
| Boldenone | 500g | 50g | 750g | 5kg | — | — |
| Bolenol | 500g | 50g | 750g | 5kg | — | — |
| 4-Bromo-2,5-dimethoxyamphetamine | 15 DDU or 0.075g | 4 DDU or 0.02g | 25 DDU or 0.125g | 0.0125kg | 0.05kg | 0.005g |
| 4-Bromo-3,5-dimethoxyamphetamine | 15 DDU or 0.075g | 4 DDU or 0.02g | 25 DDU or 0.125g | 0.0125kg | 0.05kg | 0.005g |
| 4-Bromo-2,5-dimethoxyphenethylamine | 15 DDU or 0.3g | 4 DDU or 0.08g | 25 DDU or 0.5g | 0.025kg | 0.1kg | 0.02g |
| 3-Bromo-4-methoxyamphetamine | 15 DDU or 0.075g | 4 DDU or 0.02g | 25 DDU or 0.125g | 0.0125kg | 0.05kg | 0.005g |
| 4-Bromo-3-methoxyamphetamine | 15 DDU or 0.075g | 4 DDU or 0.02g | 25 DDU or 0.125g | 0.0125kg | 0.05kg | 0.005g |
| Bufotenine and its derivatives being those derivatives having hallucinogenic properties | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 500.0g | 2.0kg | 0.2g |
| Buprenorphine | 12g | 4g | 20g | 2kg | 8kg | 400mg |
| 1,4-Butanediol | 30.0g | 10.0g | 50.0g | 1.0kg | 4.0kg | — |
| Butobarbitone | 30.0g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| Butorphanol | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-Butyl-3-(1-naphthoyl)indole (JWH-073) | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Calusterone | 500g | 50g | 750g | 5kg | — | — |
| Cannabis leaf (excluding any exception listed under the matter relating to Tetrahydrocannabinol and its alkyl homologues) | 300.0g | 30.0g | 1 000.0g | 25.0kg | 100.0kg | — |
| Cannabis oil (excluding any exception listed under the matter relating to Tetrahydrocannabinol and its alkyl homologues) | 5.0g | 2.0g | 10.0g | 500.0g | 2.0kg | — |
| Cannabis plant cultivated by enhanced indoor means | — | 5 | 50 | 50 | 200 | — |
| Cannabis plant—other | — | 5 | 50 | 250 | 1 000 | — |
| Cannabis resin | 30.0g | 5.0g | 90.0g | 2.5kg | 10.0kg | — |
| [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate (URB-597) | 30g | 10g | 50g | 1kg | 4kg | — |
| Carfentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Cathinone | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Chlorandrostenolone | 500g | 50g | 750g | 5kg | — | — |
| 1-Chloro-1-phenyl-2-aminopropane | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-Chloro-1-phenyl-2-methylamino-propane | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-(3-Chlorophenyl)-piperazine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Clonitazene | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Clostebol | 500g | 50g | 750g | 5kg | — | — |
| Coca leaf | 30.0g | 5.0g | 90.0g | 2.5kg | 10.0kg | — |
| Cocaine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| Codeine | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Codeine-N-oxide | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Codoxime | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Concentrate of poppy straw | 30.0g | 10.0g | 50.0g | 2.5kg | 10.0kg | — |
| 4-Cyano-2-dimethyl-amino-4,4-diphenyl-butane (methadone intermediate) | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 4-Cyano-1-methyl-4-phenylpiperidine (pethidine intermediate A) | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Cyclobarbitone | 30.0g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| Cyclohexyl-[1,1-biphenyl]-3-ylcarbamate (URB-602) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (RCS-8) | 30g | 10g | 50g | 1kg | 4kg | — |
| Danazol | 500g | 50g | 750g | 5kg | — | — |
| Desomorphine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Desoxypipradrol (2-DPMP) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| Dexamphetamine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| Dextromoramide | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Dextropropoxyphene | 30.0g | 10.0g | 50.0g | 2.5kg | 10.0kg | — |
| Diamorphine—see heroin | | | | | | |
| Diampromide | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Diethylthiambutene | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| N,N-Diethyltryptamine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Difenoxin | 0.6g | 0.2g | 1.0g | 0.1kg | 0.4kg | — |
| Dihydrocodeine | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Dihydrolone | 500g | 50g | 750g | 5kg | — | — |
| Dihydromorphine | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Dimenoxadol | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Dimepheptanol | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Dimethandrostanolone | 500g | 50g | 750g | 5kg | — | — |
| 2,4-Dimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,5-Dimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 3,4-Dimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,5-Dimethoxy-4-bromoamphetamine (DOB) | 15 DDU or 0.075g | 4 DDU or 0.02g | 25 DDU or 0.125g | 0.0125kg | 0.05kg | 0.005g |
| 3,4-Dimethoxy-5-ethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,5-Dimethoxy-4-ethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 4,5-Dimethoxy-2-ethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,5-Dimethoxy-4-ethylamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,5-Dimethoxy-4-methylamphetamine and other substances structurally derived from methoxyphenylethylamine being those substances having hallucinogenic properties | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| Dimethylthiambutene | 30.0g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| 2,3-Dimethoxy-4,5-methylenedioxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,5-Dimethoxy-3,4-methylenedioxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2-(2,5-dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25D-NBOMe) | 15 DDU or 0.003g | 4DDU or 0.0008g | 25 DDU or 0.005g | 0.0005kg | 0.002kg | 0.0002g |
| 3,4-Dimethoxyphenylethylamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| N, N-Dimethylamphetamine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1,3-dimethylamylamine (DMAA or methylhexanamine) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10- tetrahydro-6,6, 9-trimethyl-6H-dibenzo (b,d)pyran | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.5kg | 2.0kg | 0.2g |
| 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47, 497) | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (Cannabicyclohexanol or CP 47, 497 C8 Homologue) | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| N,N-Dimethyltryptamine and its derivatives being those derivatives having hallucinogenic properties | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.5kg | 2.0kg | 0.2g |
| Dioxaphetyl butyrate | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Diphenoxylate | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Dipipanone | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Dronabinol (Delta-9-tetrahydrocannabinol) | 0.6g | 0.2g | 1.0g | 0.1kg | 0.5kg | — |
| Drostanolone | 500g | 50g | 750g | 5kg | — | — |
| Drotebanol | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Ecgonine and its esters and derivatives which are convertible to ecgonine and cocaine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| Enestebol | 500g | 50g | 750g | 5kg | — | — |
| Ephedrine | 15.0g | 5.0g | 25.0g | 1.25kg | 5.0kg | — |
| Epitiostanol | 500g | 50g | 750g | 5kg | — | — |
| Ergotamine | 0.3g | 0.1g | 0.5g | 0.025kg | 0.1kg | — |
| Erythroxylon species | 30.0g | 5.0g | 90.0g | 2.5kg | 10.0kg | — |
| Ethylamphetamine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| Ethyldienolone | 500g | 50g | 750g | 5kg | — | — |
| 4,5-Ethylenedioxy-3-methoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.5kg | 2.0kg | 0.2g |
| N-Ethyl-3,4-methylenedioxyamphetamine | 0.75g | 0.25g | 1.25g | 0.125kg | 0.5kg | — |
| Ethylmethylthiambutene | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Ethylmorphine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Ethyloestrenol | 500g | 50g | 750g | 5kg | — | — |
| N-Ethyl-1-phenylcyclohexylamine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Etonitazene | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Etorphine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Etoxeridine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Fenethylline | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Fentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Flunitrazepam | 0.6g | 0.2g | 1g | 0.1kg | 0.5kg | — |
| Fluoromethylamphetamine | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 1-(5-fluoropentyl)-3-(1-adamantylamido)indole (STS-135) | 30g | 10g | 50g | 1kg | 4kg | — |
| [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (XLR-11) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (MAM-2201) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201) | 30g | 10g | 50g | 1kg | 4kg | — |
| Fluoxymesterone | 500g | 50g | 750g | 5kg | — | — |
| Formebolone | 500g | 50g | 750g | 5kg | — | — |
| N-formylamphetamine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| N-formylmethylamphetamine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| Furazabol | 500g | 50g | 750g | 5kg | — | — |
| Furethidine | 1.5g | 0.5g | 2.5g | 0.25kg | 1.0kg | — |
| Gamma butyrolactone | 30.0g | 10.0g | 50.0g | 1.0kg | 4.0kg | — |
| Harmaline | 15 DDU or 0.003g | 4 DDU or 0.0008g | 25 DDU or 0.005g | 0.0005kg | 0.002kg | 0.0002g |
| Harmine | 15 DDU or 0.003g | 4 DDU or 0.0008g | 25 DDU or 0.005g | 0.0005kg | 0.002kg | 0.0002g |
| Heroin | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9- trimethyl-6H-dibenzo (b,d)pyran | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.5kg | 2.0kg | 0.2g |
| 1-hexyl-3-(1-naphthoyl)indole (JWH-019) | 30g | 10g | 50g | 1kg | 4kg | — |
| Hydrocodone | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Hydromorphinol | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Hydromorphone | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 4-Hydroxybutanoic acid | 30.0g | 10.0g | 50.0g | 1.0kg | 4.0kg | — |
| 9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (HU-210) | 30g | 10g | 50g | 1kg | 4kg | — |
| N-Hydroxy-3,4-methylenedioxyamphetamine | 0.75g | 0.25g | 1.25g | 0.125kg | 0.5kg | — |
| Hydroxypethidine | 7.5g | 5.0g | 12.5g | 1.25kg | 5.0kg | — |
| Hydroxystenozol | 500g | 50g | 750g | 5kg | — | — |
| P-Iodo-N-isopropyl-amphetamine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Isomethadone | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Ketamine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Ketobemidone | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Levamphetamine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Levomethamphetamine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Levomethorphan | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Levomoramide | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Levophenacylmorphan | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Levorphanol | 1.5g | 0.5g | 2.5g | 0.25kg | 1.0kg | — |
| Lisdexamfetamine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Lysergic acid and its derivatives being those derivatives having hallucinogenic properties | 15 DDU or 0.003g | 4 DDU or 0.0008g | 25 DDU or 0.005g | 0.0005kg | 0.002kg | 0.0002g |
| Lysergide and its derivatives being those derivatives having hallucinogenic properties | 15 DDU or 0.003g | 4 DDU or 0.0008g | 25 DDU or 0.005g | 0.0005kg | 0.002kg | 0.0002g |
| Mebolazine | 500g | 50g | 750g | 5kg | — | — |
| Mecloqualone | 75.0g | 25.0g | 125.0g | 12.5kg | 50.0kg | — |
| Mepitiostane | 500g | 50g | 750g | 5kg | — | — |
| Mesabolone | 500g | 50g | 750g | 5kg | — | — |
| Mescaline | 15 DDU or 11.25g | 4 DDU or 3.0g | 50 DDU or 18.75g | 1.875kg | 7.5kg | 0.75g |
| Mestanolone | 500g | 50g | 750g | 5kg | — | — |
| Mesterolone | 500g | 50g | 750g | 5kg | — | — |
| Metazocine | 10.5g | 3.5g | 17.5g | 1.75kg | 7.0kg | — |
| Methadone except in oral liquid form | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Methadone in oral liquid form | 600ml | 200ml | 1L | 100L | 400L | — |
| Methandienone | 500g | 50g | 750g | 5kg | — | — |
| Methandriol | 500g | 50g | 750g | 5kg | — | — |
| Methaqualone | 75.0g | 25.0g | 125.0g | 12.5kg | 50.0kg | — |
| Methcathinone | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Methenolone | 500g | 50g | 750g | 5kg | — | — |
| Methiopropamine | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| Methorphan | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Methoxetamine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| 4-Methoxyamphetamine (also known as Paramethoxyamphetamine) | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| N-(2-methoxybenzyl)-2,5-dimethoxy-4-bromophenethylamine (25B-NBOMe) | 15 DDU or 0.003g | 4DDU or 0.0008g | 25 DDU or 0.005g | 0.0005kg | 0.002kg | 0.0002g |
| N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) | 15 DDU or 0.003g | 4DDU or 0.0008g | 25 DDU or 0.005g | 0.0005kg | 0.002kg | 0.0002g |
| N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOMe) | 15 DDU or 0.003g | 4DDU or 0.0008g | 25 DDU or 0.005g | 0.0005kg | 0.002kg | 0.0002g |
| 4-Methoxymethylamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2-Methoxy-3,4-methylenedioxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2-Methoxy-4,5-methylenedioxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 3-Methoxy-4,5-methylenedioxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 4-Methoxy-2,3-methylenedioxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 5-Methoxy-3,4-methylenedioxyamphetamine (MMDA) | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.5kg | 2.0kg | 0.2g |
| 2-Methoxy-3,4-methylenedioxyphenylethylamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 3-Methoxy-4,5-methylenedioxyphenylethylamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 1-(3-methoxy-4,5-methylenedioxyphenyl)-2-propanamine | 0.75g | 0.25g | 1.25g | 0.125kg | 0.5kg | — |
| 4-methoxyphenyl(1butyl-1H-indol-3-yl)-methanone (RCS-4 (C4)) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 4-Methoxyphenylethylamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2-(4-methoxyphenyl)-1-(1-pentyl-1h-indol-3-yl)-ethanone (JWH 201) | 30g | 10g | 50g | 1kg | 4kg | — |
| 2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (JWH-250) | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 2-(3-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (JWH302) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-(4-Methoxyphenyl)-piperazine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Methylamphetamine | 3.0g | 1.0g | 5.0g | 0.25kg | 0.5kg | — |
| Methylclostebol | 500g | 50g | 750g | 5kg | — | — |
| Methyldesorphine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Methyldihydromorphine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 5,6-methylenedioxy-2-aminoindane (MDAI) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 3,4-Methylenedioxyamphetamine | 0.75g | 0.25g | 1.25g | 0.125kg | 0.5kg | — |
| 3,4-methylenedioxymethcathinone (methylone) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 3,4-Methylenedioxymethylamphetamine | 0.75g | 0.25g | 1.25g | 0.125kg | 0.5kg | — |
| 3,4-Methylenedioxy-phenyl-2-propanone | 0.75g | 0.25g | 1.25g | 0.125kg | 0.5kg | — |
| 3,4-methylenedioxypyrovalerone (MDPV) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 4-methylethylcathinone (4-MEC) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| 3-Methylfentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| N-Methyl-1-(3,4-methylenedioxyphenyl)-butanamine | 0.75g | 0.25g | 1.25g | 0.125kg | 0.5kg | — |
| N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine | 0.75g | 0.25g | 1.25g | 0.125kg | 0.5kg | — |
| 2-Methyl-3-morpholino-1,1-diphenylpropane carboxylic acid (Moramide intermediate) | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Methylphenidate | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 1-Methyl-4-phenylpiperidine-4-carboxylic acid (Pethidine intermediate C) | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-Methyl-4-phenyl-4-propionoxypiperidine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-[(N-methylpiperidin-2-yl)methyl]3-(1-adamantoyl)indole (AM-1248) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-[(N-methylpiperidin-2-yl)methyl]3-(2-iodobenzoyl) indole (AM-2233) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-[(N-methylpiperidin-2-yl)methyl]3-(4-methyl-1-naphthoyl)indole (MAM-1220) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-[(N-methylpiperidin-2-yl)methyl]3-(1-naphthoyl)indole (AM-1220) | 30g | 10g | 50g | 1kg | 4kg | — |
| Methyltestosterone | 500g | 50g | 750g | 5kg | — | — |
| 4-Methylthioamphetamine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 3-Methylthiofentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Methyltrienolone | 500g | 50g | 750g | 5kg | — | — |
| Metopon | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Metribolone | 500g | 50g | 750g | 5kg | — | — |
| Mibolerone | 500g | 50g | 750g | 5kg | — | — |
| Monoacetylmorphine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 6-Monoacetylmorphine and other acetylated derivatives of morphine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Moramide | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Morphan | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Morpheridine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Morphine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Morphine methobromide | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Morphine-N-oxide | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Myrophine | 30.0g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| Nabilone | 0.6g | 0.2g | 1.0g | 0.1kg | 0.5kg | — |
| Nandrolone | 500g | 50g | 750g | 5kg | — | — |
| Naphthylpyrovalerone (Naphyrone) | 3g | 1g | 5g | 0.5kg | 2.0kg | — |
| Nicocodine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Nicodicodine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Nicomorphine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Noracylmethadol | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Norandrostenolone | 500g | 50g | 750g | 5kg | — | — |
| Norbolethone | 500g | 50g | 750g | 5kg | — | — |
| Norclostebol | 500g | 50g | 750g | 5kg | — | — |
| Norcodeine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Norethandrolone | 500g | 50g | 750g | 5kg | — | — |
| Norlevorphanol | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Normethadone | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Normethandrone | 500g | 50g | 750g | 5kg | — | — |
| Normorphine | 30.0g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| Norpipanone | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Opium | 30.0g | 10.0g | 50.0g | 1.0kg | 4.0kg | — |
| Ovandrotone | 500g | 50g | 750g | 5kg | — | — |
| Oxabolone | 500g | 50g | 750g | 5kg | — | — |
| Oxandrolone | 500g | 50g | 750g | 5kg | — | — |
| Oxycodone | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Oxymesterone | 500g | 50g | 750g | 5kg | — | — |
| Oxymetholone | 500g | 50g | 750g | 5kg | — | — |
| Oxymorphone | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Papaver somniferum and papaver orientale | 30.0g | 10.0g | 50.0g | 2.5kg | 10.0kg | — |
| Parafluorofentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Pentazocine | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Pentobarbitone | 30.0g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| 1-pentyl-3-(1-adamantoyl)indole (AB-001) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH 203) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH 210) | 30g | 10g | 50g | 1kg | 4kg | — |
| (1-pentylindol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-pentyl-3-[(4-methoxy)-benzoyl]indole (RCS-4) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-pentyl-3-(2-methoxybenzoyl)indole (RCS-4 (2-methoxy isomer)) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081) | 30g | 10g | 50g | 1kg | 4kg | — |
| 1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 1-Pentyl-3-(1-naphthoyl)indole (JWH-018) | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Pethidine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Phenacylmorphan | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Phenadoxone | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Phenampromide | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Phenazocine | 1.5g | 0.5g | 2.5g | 0.25kg | 1.0kg | — |
| Phencyclidine | 3.0g | 1.0g | 5.0g | 250.0g | 1.0kg | — |
| Phendimetrazine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Phenmetrazine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Phenomorphan | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Phenoperidine | 1.5g | 0.5g | 2.5g | 0.25kg | 1.0kg | — |
| 1-Phenyl-2-chloropropane | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-(1-phenylcyclohexyl) pyrrolidine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-Phenylethyl-4-acetoxypiperidine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-Phenyl-2-nitropropene | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 4-Phenylpiperidine-4-carboxylic acid ethyl ester (Pethidine intermediate B) | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-Phenyl-2-propanol | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Phenylpropanolamine | 15.0g | 5.0g | 25.0g | 1.25kg | 5.0kg | — |
| 1-Phenyl-2-propanone | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-Phenyl-2-propanone oxime | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Pholcodine | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Piminodine | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| Piritramide | 1.5g | 0.5g | 2.5g | 0.25kg | 1.0kg | — |
| Prasterone (dehydroepiandrosterone (dhea) or dehydroisoandrosterone (dhia)) | 500g | 50g | 750g | 5kg | — | — |
| Pravadoline (WIN 48098) | 30g | 10g | 50g | 1kg | 4kg | — |
| Proheptazine | 1.5g | 0.5g | 2.5g | 0.25kg | 1.0kg | — |
| Prohibited plant, other than cannabis plant | — | 5 | 50 | 250 | 1000 | — |
| Properidine | 37.5g | 12.5g | 62.5g | 6.25kg | 25.0kg | — |
| Propetandrol | 500g | 50g | 750g | 5kg | — | — |
| Propiram | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| 1-propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015) | 30g | 10g | 50g | 1kg | 4kg | — |
| Pseudoephedrine | 15.0g | 5.0g | 25.0g | 1.25kg | 5.0kg | — |
| Psilocin and its derivatives being those derivatives having hallucinogenic properties | 15 DDU or 0.15g | 4 DDU or 0.04g | 25 DDU or 0.25g | 25.0g | 100.0g | 0.01g |
| Psilocybin and its derivatives being those derivatives having hallucinogenic properties | 15 DDU or 0.15g | 4 DDU or 0.04g | 25 DDU or 0.25g | 25.0g | 100.0g | 0.01g |
| Quinalbarbitone | 30.0g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| Quinbolone | 500g | 50g | 750g | 5kg | — | — |
| Racemethorphan | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Racemoramide | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Racemorphan | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Remifentanil | 0.3g | 0.1g | 0.5g | 0.05kg | 0.2kg | — |
| Roxibolone | 500g | 50g | 750g | 5kg | — | — |
| Secbutobarbitone | 30.0g | 10.0g | 50.0g | 5.0kg | 20.0kg | — |
| Silandrone | 500g | 50g | 750g | 5kg | — | — |
| Stanolone | 500g | 50g | 750g | 5kg | — | — |
| Stanozolol | 500g | 50g | 750g | 5kg | — | — |
| Stenbolone | 500g | 50g | 750g | 5kg | — | — |
| Sufentanil | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Tapentadol | 7.5g | 2.5g | 12.5g | 1.25kg | 5.0kg | — |
| Testolactone | 500g | 50g | 750g | 5kg | — | — |
| Testosterone | 500g | 50g | 750g | 5kg | — | — |
| Tetrahydrocannabinol and its alkyl homologues except—(a) where separately specified in this Schedule, or(b) in hemp seed oil, containing 50mg/kg or less of tetrahydrocannabinols, when labelled “Not for internal use” or “Not to be taken”, or(c) in products for purposes other than internal human use containing 50 mg/kg or less of tetrahydrocannabinols, or(d) hemp seeds for human consumption containing 5mg/kg or less of tetrahydrocannabinols where the seeds have had their hulls removed and are non-viable, or(e) hemp seed oil for human consumption containing 10mg/kg or less of tetrahydrocannabinols, or(f) beverages made from hemp seeds if the beverage contains 0.2mg/kg or less of tetrahydrocannabinols | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 2,3,4,5-Tetramethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| Thebacon | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| Thebaine | 3.0g | 1.0g | 5.0g | 0.5kg | 2.0kg | — |
| 1-(1-(2-thienyl) cyclohexyl)-piperidine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Thiofentanyl | 0.0075g | 0.0025g | 0.0125g | 0.00125kg | 0.005kg | — |
| Thiomesterone | 500g | 50g | 750g | 5kg | — | — |
| Tilidine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Trenbolone | 500g | 50g | 750g | 5kg | — | — |
| Trestolone | 500g | 50g | 750g | 5kg | — | — |
| 1-(3-Trifluoromethylphenyl)-piperazine | 3.0g | 1.0g | 5.0g | 0.25kg | 1.0kg | — |
| Trimeperidine | 15.0g | 5.0g | 25.0g | 2.5kg | 10.0kg | — |
| 2,3,4-Trimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,3,5-Trimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,3,6-Trimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,4,5-Trimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,4,6-Trimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 3,4,5-Trimethoxyamphetamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 1-(3,4,5-Trimethoxyphenyl)-2-aminobutane | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| 2,4,5-Trimethoxyphenylethylamine | 15 DDU or 3.0g | 4 DDU or 0.8g | 25 DDU or 5.0g | 0.25kg | 1.0kg | 0.2g |
| Prohibited plant or prohibited drug |
| Any substance that is an analogue of a drug prescribed in this Schedule is not separately specified in this Schedule and is, in relation to the drug, any of the following—(a) a structural isomer having the same constituent groups as the drug,(b) a structural modification obtained in one or more of the following ways—(i) the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures,(ii) the addition of hydrogen atoms to 1 or more unsaturated bonds,(iii) the addition of 1 or more of the following groups having up to 6 carbon atoms in any alkyl residue, namely, alkoxy, cyclic diether, acyl, acyloxy, monoalkylamino and dialkylamino groups,(iv) the addition of 1 or more of the following groups having up to 6 carbon atoms in the group and being attached to oxygen, namely, alkyl, alkenyl and alkynyl groups (for example, ester groups and ether groups),(v) the addition of 1 or more of the following groups having up to 6 carbon atoms in the group and being attached to nitrogen, sulphur or carbon, namely, alkyl, alkenyl and alkynyl groups,(vi) the addition of 1 or more of the following groups, namely, halogen, hydroxy, nitro and amino groups,(vii) the replacement of 1 or more of the groups specified in subparagraphs (iii)–(vi) with 1 or more other groups so specified,(viii) the conversion of a carboxyl or an ester group into an amide group. |
| Column 1 |
| Traffickable quantity |
| The quantity specified above (if any) of the drug to which the analogous substance is related (or, if there is more than one such drug, the largest among the quantities specified above (if any) of those drugs). |
| Column 2 |
| Small quantity |
| The quantity specified above (if any) of the drug to which the analogous substance is related (or, if there is more than one such drug, the largest among the quantities specified above (if any) of those drugs). |
| Column 3 |
| Indictable quantity |
| The quantity specified above (if any) of the drug to which the analogous substance is related (or, if there is more than one such drug, the largest among the quantities specified above (if any) of those drugs). |
| Column 4 |
| Commercial quantity |
| The quantity specified above (if any) of the drug to which the analogous substance is related (or, if there is more than one such drug, the largest among the quantities specified above (if any) of those drugs). |
| Column 5 |
| Large commercial quantity |
| The quantity specified above (if any) of the drug to which the analogous substance is related (or, if there is more than one such drug, the largest among the quantities specified above (if any) of those drugs). |
| Column 6 |
| Discrete dosage unit (DDU) |
| The quantity specified above (if any) of the drug to which the analogous substance is related (or, if there is more than one such drug, the largest among the quantities specified above (if any) of those drugs). |
**sch 1:** Am GG No 136 of 29.8.1986, p 4184; GG No 109 of 26.6.1987, p 3391 (on and from 1.7.1987); GG No 33 of 19.2.1988, p 953. Subst 1988 No 17, Sch 1 (9). Am 1988 No 63, Sch 1 (2); GG No 65 of 18.5.1990, p 3901 (on and from 3.6.1990); GG No 134 of 27.9.1991, p 8341 (on and from 20.10.1991); GG No 82 of 23.7.1993, p 4052 (on and from 25.7.1993); GG No 136 of 7.10.1994, p 6165 (on and from 10.10.1994); GG No 83 of 7.7.1995, p 3581; GG No 102 of 25.8.1995, p 4453; GG No 131 of 27.10.1995, p 7419 (on and from 1.11.1995); GG No 117 of 18.10.1996, p 6959; GG No 146 of 13.12.1996, p 8254 (on and from 20.12.1996); GG No 18 of 14.2.1997, p 548; GG No 6 of 13.1.1999, p 113; GG No 27 of 5.3.1999, p 1553; GG No 105 of 18.8.2000, p 7749 (on and from 21.8.2000); GG No 156 of 12.10.2001, p 8518 (on and from 1.3.2002); GG No 149 of 20.9.2002, p 8201; GG No 75 of 17.4.2003, p 4527; GG No 121 of 1.8.2003, p 7537; GG No 197B of 19.12.2003, p 11591; 2006 No 39, Sch 1 \[24\] \[26\]; 2006 No 57, Sch 1 \[17\]; 2007 No 57, Sch 4 \[10\] \[11\]; 2009 (221), cl 3 (1) (2); 2011 (347), Sch 1; 2013 No 70, Sch 1 \[8\]; 2013 (556), Sch 1; 2014 No 2, Sch 4; 2014 No 88, Sch 2.18; 2015 (527), cl 3; 2016 (211), Sch 1 \[1\]–\[5\]; 2017 No 44, Sch 1.11 \[1\] \[2\]; 2018 No 29, Sch 1.12 \[2\]; 2019 No 10, Sch 1.12 \[1\]–\[6\]; 2020 No 26, Sch 1.9\[1\] \[2\]; 2021 (157), Sch 1\[1\]–\[9\]; 2021 (158), cl 3; 2023 No 7, Schs 1.7, 2.22.